Page 27 - Generation Sequencing News Today

Image in public domain (via Wiki Commons). Despite our differences, human beings share 99.9% of the genome. In other words, we all differ by a mere 0.1% of genes, which triggers the difference in the way we appear, grow, and develop. Over 80% of rare diseases are caused by genetic mutations in that miniscule difference, and it’s estimated that such undiagnosed diseases affect about 8% of our population. Detecting such diseases is challenging, but researchers are working on new promising techn...

Share this article Share this article ResearchAndMarkets.coms offering. Multiplexed diagnostics can detect multiple analytes in a sample through a single run. Multiplexed assays are used in the detection of cancers, infectious diseases and functional biomolecules such as (DNA and mRNA). Multiplexed assays aid in disease diagnosis, molecular diagnosis, and drug development. Multiplexed diagnostics is capable to detect analytes in the limited sample and in short span of time by analyzing hundred...

Share this article Share this article ResearchAndMarkets.coms offering. The Global Companion Diagnostics Market size was valued at USD 1.96 billion in 2019 and is predicted to reach USD 9.02 billion by 2030, with a CAGR of 14.8% from 2020-2030. Companion Diagnostic (CDx) is a clinical test co-developed with a therapeutic drug for screening the responders and non-responders to that particular drug. It is done in order to identify a patient group that can or cannot be treated with that correspon...

Share: ResearchAndMarkets.coms offering. The Global Companion Diagnostics Market size was valued at USD 1.96 billion in 2019 and is predicted to reach USD 9.02 billion by 2030, with a CAGR of 14.8% from 2020-2030. Companion Diagnostic (CDx) is a clinical test co-developed with a therapeutic drug for screening the responders and non-responders to that particular drug. It is done in order to identify a patient group that can or cannot be treated with that corresponding drug. CDx helps practition...

PerkinElmer Inc. (U.S.) Eurofins LifeCodexx GmbH (Germany) COVID-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers The COVID-19 pandemic has had an adverse effect on several industries across the world. Several reputed companies operating in the non-invasive prenatal testing industry are constantly keeping in touch with the U.S. FDA to get to know detailed information about supply chain disruptions. Also, research institutes are conducting many studies to determine the effect of the co...

Posted on 716 ResearchAndMarkets.com’s offering. The Global Next Generation Cancer Diagnostics Market is expected to grow from USD 5,693.79 Million in 2020 to USD 15,738.27 Million by the end of 2025. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. ...

Global Increase in Mental Health Burden Market Challenges Lack of Awareness for Precision Psychiatry Diagnostics Market Opportunities Massive Scope for Adoption of NGS-Based Genetic Tests in Emerging Markets Key Companies Profiled Illumina, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Quest Diagnostics Incorporated, ARUP Laboratories, Invitae Corporation, OPKO Health, Inc., Laboratory Corporation of America Holdings, Centogene N.V., Thermo Fisher Scientific Inc., My...

Share this article Share this article ResearchAndMarkets.coms offering. The Global Liquid Handling System Market is estimated to be USD 3.3 Bn in 2020 and is expected to reach USD 4.65 Bn by 2025, growing at a CAGR of 7.1%. Market Dynamics Major factors that drive the market growth are increasing expenditure in research & development activities, growing technological advancements, the need for new drug development, and the growing demand for high-output screening. All these help in driving the...

Next Generation Sequencing (NGS) Market to See Huge Growth by 2026 Facto Market Insights recently published market research report on the Global Next Generation Sequencing (NGS) Market to its collection of market research reports. BriefingWire.com, 4/05/2021 - Facto Market Insights recently published market research report on the Global Next Generation Sequencing (NGS) Market to its collection of market research reports. The research report cover...

The market research report provides detailed analysis of market drivers, challenges, opportunity analysis, and trend BriefingWire.com, 3/10/2021 - The Global Biomarker Technologies Market 2021-2025 Report provides an in-depth analysis on the studied market that helps to seem at the longer term requirement also as prediction. The Biomarker Technologies Market Report evaluates the market by key market players, opportunities, value, trends, growth, market share, ma...